C

    Collegium Pharmaceutical Inc (COLL)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $24.61
    -0.74 (-2.92%)

    Market Cap: $785.83M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +10.69%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$1.86
    Range$1.75 - $2.01
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$2.08+11.6%
    60d ago$2.08+11.6%
    30d ago$2.09+12.4%
    7d ago$1.87+0.3%
    Current$1.86
    Revenue Consensus
    $218M
    Range$215M - $222M
    4 analysts
    Dec 31, 2026
    EPS Consensus$2.32
    Range$2.13 - $2.57
    4 analysts
    Revenue Consensus
    $233M
    Range$226M - $242M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.32---
    Sep 26EST
    		-$1.86---
    Jun 26
    		$1.57$1.48+6.08%Beat+6.8%
    Mar 26
    		$1.76$1.52+15.79%Beat+18.1%
    Dec 25
    		$1.85$2.01-7.96%Miss+4.5%
    Sep 25
    		$2.25$1.86+20.97%Beat+39.8%
    Jun 25
    		$1.47$1.43+2.80%Beat-9.3%
    Mar 25
    		$1.49$1.45+2.76%Beat+2.8%
    Dec 24
    		$1.77$1.54+15.12%Beat+12.0%
    Sep 24
    		$1.61$1.59+1.26%Beat+20.1%
    Jun 24
    		$1.62$1.49+8.72%Beat+28.6%
    Mar 24
    		$1.45$1.47-1.36%Miss+9.8%
    Dec 23
    		$1.58$1.25+26.40%Beat+852.4%
    Sep 23
    		$1.34$1.24+8.06%Beat+21.8%
    Jun 23
    		$1.26$1.22+3.28%Beat+4.1%
    Mar 23
    		$1.32$1.51-12.58%Miss+45.1%
    Dec 22
    		$-0.21$-0.14-50.00%Miss+58.8%
    Sep 22
    		$1.10$1.38-20.29%Miss+41.0%
    Jun 22
    		$1.21$1.44-15.97%Miss+49.4%
    Mar 22
    		$0.91$0.90+1.11%Beat-5.2%
    Dec 21
    		$-0.51N/A-149.04%Miss-355.0%
    Sep 21
    		$0.78$0.96-18.75%Miss-24.3%
    Jun 21
    		$0.81$0.95-14.74%Miss-14.7%
    Mar 21
    		$0.96$1.00-4.00%Miss+9500.0%
    Dec 20
    		$0.20$0.39-48.72%Miss+25.0%
    Sep 20
    		$1.03$0.90+14.44%Beat+1960.0%
    Jun 20
    		$0.95$0.86+10.47%Beat+955.6%
    Mar 20
    		$0.01N/A-97.56%Miss+120.0%
    Dec 19
    		$0.16$0.10+60.00%Beat-40.7%
    Sep 19
    		$0.05$0.03+66.67%Beat+120.0%
    Jun 19
    		$0.09$-0.04+325.00%Beat+160.0%
    Mar 19
    		$-0.05N/A+66.67%Beat+91.2%
    Dec 18
    		$0.27$-0.35+177.14%Beat+150.0%
    Sep 18
    		$-0.25$-0.12-108.33%Miss+44.4%
    Jun 18
    		$-0.15N/A+54.55%Beat+79.2%
    Mar 18
    		$-0.57$-0.65+12.31%Beat+27.8%
    Dec 17
    		$-0.54$-0.57+5.26%Beat+47.1%
    Sep 17
    		$-0.45$-0.73+38.36%Beat+60.2%
    Jun 17
    		$-0.72$-0.80+10.00%Beat-
    Mar 17
    		$-0.79$-1.00+21.00%Beat-
    Dec 16
    		$-1.02$-1.07+4.67%Beat-
    Sep 16
    		$-1.13$-1.11-1.80%Miss-

    Key Metrics

    Valuation
    P/E Ratio3.31EV/EBITDA4.71x
    Price/FCF2.43xFCF Yield41.09%
    Profitability
    Profit Margin5.93%Operating Margin5.65%
    ROE17.60%ROIC7.21%
    Financial Health
    Debt/Equity3.55xInterest Coverage1.70x
    Current Ratio1.03xQuick Ratio0.84x
    Trading Statistics
    Beta0.76Avg Volume871.52K
    52-Week High$50.7952-Week Low$25.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$27.06
    SMA 20$28.20
    SMA 50$32.71
    SMA 200$38.50
    EMA 10$26.81
    EMA 20$28.40
    EMA 50$31.20
    EMA 200$35.07

    MACD

    Line: -2.05Signal: -1.92Hist: -0.13

    ADX

    ADX: 27.4+DI: 16.6-DI: 36.9

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$27.76

    Bollinger Bands

    Upper Band$33.93
    Lower Band$22.47
    %B Position4065%(Upper)
    Band Width0.19

    RSI (14-Day)

    Oversold
    25.8

    Momentum Oscillators

    Stoch %K10.1
    Stoch %D22.4
    Williams %R-97.2
    ROC (10d)-12.3%
    Momentum-3.46
    CCI (20d)-131.9
    MFI (14d)51.9

    Volatility Measures

    ATR (14d)$1.41(5.7%)
    StdDev (20d)2.87
    Hist Vol83.5%(High)

    Volume Flow

    VWAP$24.82
    OBV17.0M
    AD Line-6.1M
    CMF (20d)-0.406

    Volume Metrics

    Avg Vol (20d)896.4K
    Vol Ratio1.2x
    VWMA (20d)$27.82

    Pivot Points

    R3$27.83
    R2$27.26
    R1$26.30
    Pivot Point$25.73
    S1$24.78
    S2$24.21
    S3$23.25

    Advanced Oscillators

    TSI-37.51
    Ultimate Osc32.0
    KST-215.63

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$199.88M$193.52M$205.45M$209.36M$188.00M$177.76M$181.95M$159.30M$145.28M$144.92M$149.75M$136.71M
    Cost of Revenue$89.59M$76.27M$77.07M$80.19M$79.62M$80.43M$83.66M$62.51M$54.47M$53.47M$55.12M$56.40M
    Gross Profit$110.29M$117.25M$128.38M$129.17M$108.38M$97.32M$98.29M$96.79M$90.81M$91.46M$94.63M$80.31M
    Operating Expenses$106.59M$86.35M$67.62M$67.08M$73.28M$75.64M$60.18M$61.95M$43.34M$41.98M$32.94M$35.30M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$106.59M$86.35M$67.64M$67.10M$73.64M$76.42M$63.09M$61.95M$43.34M$41.98M$32.94M$35.30M
    Operating Income$3.70M$30.90M$60.76M$62.09M$35.10M$21.69M$38.11M$34.84M$47.47M$49.47M$61.69M$45.01M
    Interest Income$2.29M$3.71M$3.56M$3.12M$2.38M$2.23M$1.81M$3.28M$4.40M$4.49M$4.30M$4.54M
    Interest Expense$19.52M$15.86M$35.29M$21.77M$20.46M$20.79M$22.65M$22.54M$22.77M$17.34M$19.28M$20.77M
    Income Before Tax$-13,532,000$18.74M$29.04M$43.44M$17.02M$3.12M$17.27M$15.58M$29.10M$36.62M$46.71M$28.78M
    Income Tax Expense$1.52M$4.24M$12.07M$11.93M$5.04M$705,000$4.73M$6.25M$9.49M$8.91M$14.77M$8.15M
    Net Income$-15,051,000$14.50M$16.96M$31.51M$11.98M$2.42M$12.54M$9.34M$19.61M$27.71M$31.94M$20.63M
    EBITDA$69.50M$87.47M$118.17M$119.71M$92.80M$79.29M$95.67M$77.28M$83.82M$86.27M$98.55M$83.72M
    EBIT$3.70M$30.90M$60.76M$62.09M$35.10M$21.69M$38.11M$34.84M$47.47M$49.47M$61.69M$45.01M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COLL

    News

    Israel A. Englander reports new Collegium (NASDAQ: COLL) stake

    Israel A. Englander, along with Millennium Management LLC and Millennium Group Management LLC, has reported a new 5.6% beneficial stake in Collegium Pharmaceutical, Inc. (NASDAQ: COLL), owning 1,820,330 shares. Integrated Core Strategies (US) LLC also reported a 5.4% stake, holding 1,769,122 shares. The Schedule 13G filing indicates shared voting and dispositive power among these entities, with no party claiming sole voting power over the shares.

    Stock Titan•8/24/26•
    Neutral

    ETFs Investing in Collegium Pharmaceutical, Inc. Stocks

    This article lists various Exchange Traded Funds (ETFs) that hold stocks of Collegium Pharmaceutical, Inc. The ETFs are sorted by market value and provide details such as their weight of Collegium Pharmaceutical in their portfolio, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year NAV total return. The information aims to help investors identify accessible investment opportunities with lower risk through ETFs.

    TradingView•8/23/26•
    Neutral

    Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48

    Barclays has reiterated its Buy rating on Collegium Pharmaceutical (COLL.US) but has reduced its price target for the company's stock to $48. This indicates a continued positive outlook on the stock's performance, albeit with a slightly adjusted valuation expectation.

    Moomoo•8/20/26•
    Somewhat-Bearish

    Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock

    Fuller & Thaler Asset Management, Inc. has reported a beneficial ownership of 5.03% in COLLEGIUM PHARMACEUTICAL, INC (COLL) common stock, totaling 1,632,780.71 shares as of June 30, 2026. The firm holds sole voting and dispositive power over these shares, which are held in accounts for advisory clients who retain the rights to dividends and sale proceeds. This disclosure was made via a SCHEDULE 13G filing with the SEC.

    Stock Titan•8/14/26•
    Neutral

    COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56

    Needham has revised its target price for Collegium Pharmaceutical Inc (NASDAQ: COLL) downwards from $56 to $46. This article, published on August 7th, highlights the analyst's updated outlook on the pharmaceutical company.

    Webull•8/14/26•
    Bearish

    Frequently Asked Questions About COLL

    Does COLL pay dividends?
    Collegium Pharmaceutical Inc (COLL) does not currently pay a regular dividend.
    What is COLL's P/E ratio?
    Collegium Pharmaceutical Inc has a price-to-earnings (P/E) ratio of 3.31.
    What is COLL's market cap?
    Collegium Pharmaceutical Inc (COLL) has a market capitalization of $785.83M with a current stock price of $24.61.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In